Patent: 10,028,962
✉ Email this page to a colleague
Summary for Patent: 10,028,962
Title: | 2-amino-6-methy1-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,- 3-thiazol-4-yl amides |
Abstract: | The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, ##STR00001## and the variable R.sup.1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed. |
Inventor(s): | Brodney; Michael Aaron (Newton, MA), Beck; Elizabeth Mary (Oxford, GB), Butler; Christopher Ryan (Canton, MA), Zhang; Lei (Auburndale, MA), O\'Neill; Brian Thomas (Haddam, CT), Barreiro; Gabriela (Sao Paulo, BR), LaChapelle; Erik Alphie (Uncasville, CT), Rogers; Bruce Nelsen (Belmont, MA) |
Assignee: | Pfizer Inc. (New York, NY) |
Application Number: | 15/629,215 |
Patent Claims: | see list of patent claims |
Details for Patent 10,028,962
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Jubilant Hollisterstier Llc | N/A | positive skin test control-histamine | Injection | 103891 | 03/13/1924 | ⤷ Try a Trial | 2034-04-10 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |